The Genetic Data Market: Institutional Governance of Academic/Industry Research Partnerships for the Public Good
Open Access
- 23 September 2025
- journal article
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 25 (12) , 4-18
Abstract
The Trump Administration's cuts to research funding and opposition to diversity, equity, and inclusion is destabilizing academic research. These attacks coincide with pointed government support for the private sector. But the conceptualization of academic versus private sector health research has historically been a false binary. Drawing on mixed methods research, this paper examines the genomic data market as an example of advantages and challenges of commercializing academic expertise. It also highlights the structural downsides of researchers individually navigating industry partnerships. While academia is currently being put in the unenviable position of being more likely to need the private sector to conduct research, with less federal funding to offer in exchange, structural pain points have existed for decades. This is an opportunity for academia to harness its powers of expertise and collective action to develop institutional policy to ensure academic/industry research is beneficial to the public health and diverse patient communities.Keywords
Funding Information
- Greenwall Foundation (Faculty Scholars Program)
- National Center for Advancing Translational Sciences (R01TR004244)
- National Human Genome Research Institute (K01HG010496)
This publication has 83 references indexed in Scilit:
- Protecting Privacy When Genetic Databases Are CommercializedJAMA, 2025
- FDA Perspective on the Regulation of Artificial Intelligence in Health Care and BiomedicineJAMA, 2025
- Comparison of Research Spending on New Drug Approvals by the National Institutes of Health vs the Pharmaceutical Industry, 2010-2019JAMA Health Forum, 2023
- Reported Interest in Notification Regarding Use of Health Information and BiospecimensJAMA, 2022
- Incentivizing a New Culture of Data StewardshipJAMA, 2021
- Geographic Distribution of US Cohorts Used to Train Deep Learning AlgorithmsJAMA, 2020
- Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician PrescribingJAMA, 2017
- Health Industry Practices That Create Conflicts of InterestJAMA, 2006
- Data Withholding in Academic GeneticsJAMA, 2002
- Withholding Research Results in Academic Life ScienceJAMA, 1997